Preferences for colorectal cancer screening strategies: A discrete choice experiment

British Journal of Cancer

Volumn 102, Issue 6, 2010, Pages 972-980

  Hol, L ^a   De Bekker Grob, E W ^a   Van Dam, L ^a   Donkers, B ^b   Kuipers, E J ^a   Habbema, J D F ^a   Steyerberg, E W ^a   Van Leerdam, M E ^a   Essink Bot, M L ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Discrete choice experiment; Preference; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HUMAN; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SCREENING TEST; SIGMOIDOSCOPY;

AGED; ALGORITHMS; ATTITUDE TO HEALTH; CARCINOMA; CHOICE BEHAVIOR; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT PREFERENCE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; SIGMOIDOSCOPY; SURVIVAL ANALYSIS;

EID: 77949541821     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605566     Document Type: Article

References (48)

1. Cantor SB, Volk RJ, Cass AR, Gilani J, Spann SJ (2002) Psychological benefits of prostate cancer screening: the role of reassurance. Health Expect 5: 104-113
2. Commission of the European Communities. Proposal for a Council Recommendation on Cancer Screening, 2003/0093 (CNS). Brussel, 5 May 2003
3. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD (2008) Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23: 169-174
4. Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35: 1095-1108
5. Edwards A, Elwyn G, Mulley A (2002) Explaining risks: turning numerical data into meaningful pictures. BMJ 324: 827-830
6. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroentero-logy 126: 1674-1680
7. Farraye FA, Wong M, Hurwitz S, Puleo E, Emmons K, Wallace MB, Fletcher RH (2004) Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol 99: 341-349
8. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284: 1954-1961
9. Frew EJ, Wolstenholme JL, Whynes DK (2005) Eliciting relative preferences for two methods of colorectal cancer screening. Eur J Cancer Care 14: 124-131
10. Gerard K, Shanahan M, Louviere J (2008) Using discrete choice modelling to investigate breast screening participation. In Using Discrete Choice Experiments to Value Health and Health Care, Ryan M, Gerard K, Amaya-Amaya M (eds), pp 117-137. Springer: Dordrecht
11. Gyrd-Hansen D, Sogaard J (2001) Analysing public preferences for cancer screening programmes. Health Econ 10: 617-634
12. Hall J, Kenny P, King M, Louviere J, Viney R, Yeoh A (2002) Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ 11: 457-465
13. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477
14. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S (2008) Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care 46: S10-S16
15. Hoff G, Grotmol T, Skovlund E, Bretthauer M (2009) Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338: b1846
16. Hol L, van Leerdam ME, van BM, van Vuuren AJ, van DH, Reijerink JC, van der Togt AC, Habbema DJ, Kuipers EJ (2009a) Screening for colorectal cancer; randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59(1): 62-68
17. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME (2009b) Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cutoff levels. Br J Cancer 100: 1103-1110
18. Howard K, Salkeld G (2008) Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer. Value Health (in press)
19. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS (2008) Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 103: 2432-2442
20. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C (1994) Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68 308 subjects. Scand J Gastroenterol 29: 468-473
21. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471
22. Lancsar E, Louviere J (2006) Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences? Health Econ 15: 797-811
23. Langenhoff BS, Krabbe PF, Ruers TJ (2007) Computer-based decision making in medicine: a model for surgery of colorectal liver metastases. Eur J Surg Oncol 33(Suppl 2): S111-S117
24. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58: 130-160
25. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371
26. Marbet UA, Bauerfeind P, Brunner J, Dorta G, Valloton JJ, Delco F (2008) Colonoscopy is the preferred colorectal cancer screening method in a population-based program. Endoscopy 40: 650-655
27. Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van BS, Phillips KA (2009) How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 18: 1420-1439
28. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA (2007) Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 10: 415-430
29. Menees SB, Inadomi JM, Korsnes S, Elta GH (2005) Women patients' preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc 62: 219-223
30. Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32 702 veterans. Ann Intern Med 123: 904-910
31. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572-1575
32. Pignone M, Bucholtz D, Harris R (1999) Patient preferences for colon cancer screening. J Gen Intern Med 14: 432-437
33. Ryan M (2004) Discrete choice experiments in health care. BMJ 328: 360-361
34. Ryan M, Major K, Skatun D (2005) Using discrete choice experiments to go beyond clinical outcomes when evaluating clinical practice. J Eval Clin Pract 11: 328-338
35. Ryan M, Watson V, Entwistle V (2009) Rationalising the 'irrational': a think aloud study of discrete choice experiment responses. Health Econ 18: 321-336
36. Salkeld G, Solomon M, Short L, Ryan M, Ward JE (2003) Evidence-based consumer choice: a case study in colorectal cancer screening. Aust NZ J Public Health 27: 449-455
37. Sculpher M, Bryan S, Fry P, de WP, Payne H, Emberton M (2004) Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ 328: 382
38. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M (2005) Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97: 347-357
39. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS (2002) Baseline findings of the Italian multicenter randomized controlled trial of 'once-only sigmoidoscopy'-SCORE. J Natl Cancer Inst 94: 1763-1772
40. Selby JV, Friedman GD, Quesenberry Jr CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657
41. Street DJ, Burgess L, Louviere JJ (2005) Constructing. Optimal and nearly optimal stated choice experiments. Intern J Res Marketing 22: 459-470
42. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D, Lieberman DA, Chan FK (2008) Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57: 1166-1176
43. UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359: 1291-1300
44. van Rossum LG, Van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Van Krieken HH, Verbeek AL, Jansen JB, Dekker E (2008) Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135: 82-90
45. Weston A, Fitzgerald P (2004) Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma. Pharmacoeco-nomics 22: 1195-1208
46. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981
47. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S (2006) Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 96: 809-811
48. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van BM, Kuntz KM (2008) Evaluating test strategies for colorectal cancer screening: a decision analysis for the US preventive services task force. Ann Intern Med 149: 659-669